RB
ReLive Biotechnologies
ReLive develops advanced regenerative cell therapies for orthopedic sports medicine and reconstructive surgery. The company specializes in autologous cell therapies for treating joint cartilage defects, offering personalized solutions for cartilage repair and restoration. Their cell-based medicinal product is indicated for knee cartilage repair, demonstrating long-term tissue restoration confirmed by clinical trials.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$36MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- ReLive develops advanced regenerative cell therapies for orthopedic sports medicine and reconstructive surgery. The company specializes in autologous cell therapies for treating joint cartilage defects, offering personalized solutions for cartilage repair and restoration. Their cell-based medicinal product is indicated for knee cartilage repair, demonstrating long-term tissue restoration confirmed by clinical trials.